Get startedLog in
    Picture of Zynerba Pharmaceuticals logo

    ZYNE — Zynerba Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall Cap
    All News

    Brief: Zynerba Pharmaceuticals Q3 Loss Per Share $0.26

    Picture of Zynerba Pharmaceuticals logoZynerba Pharmaceuticals
    15/11/2021 12:15
    Nov 15 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
    * Q3 LOSS PER SHARE $0.26
    * CASH RUNWAY WELL INTO FIRST HALF OF 2024; $75.6 MILLION AT
SEPTEMBER 30, 2021
    * Q3 EARNINGS PER SHARE VIEW $-0.25 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9KNnPM 
Further company coverage:  ZYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Zynerba Pharmaceuticals

    See all news